Li Y, Xu C, Zhu R, Shen L, Hu G, Tao K
J Cancer Res Clin Oncol. 2023; 149(10):7235-7246.
PMID: 36905423
DOI: 10.1007/s00432-023-04670-w.
Su S, Shi Y, Chu Y, Jiang M, Wu N, Xu B
Cell Mol Life Sci. 2022; 79(2):133.
PMID: 35165763
PMC: 11073224.
DOI: 10.1007/s00018-022-04143-2.
Lu Y, Hsin C, Lu Y, Wu M, Huang J, Huang C
Sci Rep. 2021; 11(1):6229.
PMID: 33737604
PMC: 7973765.
DOI: 10.1038/s41598-021-85598-4.
Chen C, Ge X, Zhao Y, Wang D, Ling L, Zheng S
Front Oncol. 2020; 10:605349.
PMID: 33363035
PMC: 7758447.
DOI: 10.3389/fonc.2020.605349.
Chen K, Zhu P, Ye J, Liao Y, Du Z, Chen F
J Cancer. 2019; 10(22):5397-5403.
PMID: 31632484
PMC: 6775708.
DOI: 10.7150/jca.32875.
Matrix metalloproteinase-2, -9, and tissue inhibitor of MMP-2 gene polymorphisms in Taiwanese periodontitis patients.
Hsiao Y, Yang L, Chou Y, Ho Y, Lin Y, Ho K
J Dent Sci. 2019; 11(4):411-418.
PMID: 30895006
PMC: 6395246.
DOI: 10.1016/j.jds.2016.07.001.
P4HA3 is Epigenetically Activated by Slug in Gastric Cancer and its Deregulation is Associated With Enhanced Metastasis and Poor Survival.
Song H, Liu L, Song Z, Ren Y, Li C, Huo J
Technol Cancer Res Treat. 2018; 17:1533033818796485.
PMID: 30198421
PMC: 6131293.
DOI: 10.1177/1533033818796485.
Molecular alterations of cancer cell and tumour microenvironment in metastatic gastric cancer.
Li W, Ng J, Wong C, Ng E, Yu J
Oncogene. 2018; 37(36):4903-4920.
PMID: 29795331
PMC: 6127089.
DOI: 10.1038/s41388-018-0341-x.
Association of TIMP-2-418G/C and TIMP-2-303G/A with gastric cancer: a meta-analysis.
Yang Y, Xiong Y, Li J, Wu C, Jiang J
Onco Targets Ther. 2016; 9:6801-6808.
PMID: 27843330
PMC: 5098565.
DOI: 10.2147/OTT.S114113.
Relationship between single-nucleotide polymorphism of matrix metalloproteinase-2 gene and colorectal cancer and gastric cancer susceptibility: a meta-analysis.
Wu Z, Jiang P, Zulqarnain H, Gao H, Zhang W
Onco Targets Ther. 2015; 8:861-9.
PMID: 25945057
PMC: 4406259.
DOI: 10.2147/OTT.S78031.
Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.
Ben Nejima D, Ben Zarkouna Y, Gammoudi A, Manai M, Boussen H
Tumour Biol. 2015; 36(5):3815-22.
PMID: 25656607
DOI: 10.1007/s13277-014-3023-5.
Spinal cord injury induced neuropathic pain: Molecular targets and therapeutic approaches.
Schomberg D, Miranpuri G, Duellman T, Crowell A, Vemuganti R, Resnick D
Metab Brain Dis. 2015; 30(3):645-58.
PMID: 25588751
DOI: 10.1007/s11011-014-9642-0.
No correlation between TIMP2 -418 G>C polymorphism and increased risk of cancer: evidence from a meta-analysis.
Mandal R, Akhter N, Haque S, Panda A, Mittal R, Alqumber M
PLoS One. 2014; 9(8):e88184.
PMID: 25136829
PMC: 4138026.
DOI: 10.1371/journal.pone.0088184.
Expression of the matrix metalloproteases 2, 14, 24, and 25 and tissue inhibitor 3 as potential molecular markers in advanced human gastric cancer.
de la Pena S, Sampieri C, Ochoa-Lara M, Leon-Cordoba K, Remes-Troche J
Dis Markers. 2014; 2014:285906.
PMID: 24669030
PMC: 3942291.
DOI: 10.1155/2014/285906.
Gastrokine-2 is downregulated in gastric cancer and its restoration suppresses gastric tumorigenesis and cancer metastasis.
Dai J, Zhang N, Wang J, Chen M, Chen J
Tumour Biol. 2014; 35(5):4199-207.
PMID: 24408014
DOI: 10.1007/s13277-013-1550-0.
Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis.
Li X, Qu L, Zhong Y, Zhao Y, Chen H, Daru L
J Cancer Res Clin Oncol. 2013; 139(9):1433-47.
PMID: 23644699
DOI: 10.1007/s00432-013-1446-9.
Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis.
Liu D, Guo H, Li Y, Xu X, Yang K, Bai Y
PLoS One. 2012; 7(2):e31251.
PMID: 22348060
PMC: 3279370.
DOI: 10.1371/journal.pone.0031251.
Single-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer.
Langers A, Verspaget H, Hommes D, Sier C
World J Gastrointest Oncol. 2011; 3(6):79-98.
PMID: 21731908
PMC: 3124635.
DOI: 10.4251/wjgo.v3.i6.79.
S100A4 mediated cell invasion and metastasis of esophageal squamous cell carcinoma via the regulation of MMP-2 and E-cadherin activity.
Zhang H, Zheng X, Wang X, Xuan X, Wang F, Li S
Mol Biol Rep. 2011; 39(1):199-208.
PMID: 21603862
DOI: 10.1007/s11033-011-0726-1.
Inhibition of p600 expression suppresses both invasiveness and anoikis resistance of gastric cancer.
Sakai H, Ohuchida K, Mizumoto K, Cui L, Nakata K, Toma H
Ann Surg Oncol. 2011; 18(7):2057-65.
PMID: 21347795
PMC: 3115059.
DOI: 10.1245/s10434-010-1523-0.